PubRank

Frans A Kuypers

Author PubWeight™ 57.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003 2.93
2 VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med 2006 2.67
3 Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) 2008 2.28
4 Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res 2004 2.08
5 Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004 2.01
6 Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton. Blood 2010 1.99
7 Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood) 2009 1.51
8 Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci 2005 1.35
9 Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A 2007 1.33
10 Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol 2006 1.31
11 Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 2007 1.17
12 Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol 2003 1.14
13 Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood 2009 1.12
14 Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem 2010 1.08
15 Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol 2006 1.06
16 Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 2005 1.06
17 Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 2006 1.04
18 Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica 2013 0.99
19 In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica 2004 0.98
20 The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med 2009 0.96
21 Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol 2006 0.95
22 Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol 2011 0.92
23 Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med 2012 0.92
24 Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol 2005 0.92
25 A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem 2002 0.91
26 Large-scale arrays of picolitre chambers for single-cell analysis of large cell populations. Lab Chip 2010 0.91
27 Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 2004 0.90
28 A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J 2004 0.89
29 Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry 2002 0.89
30 Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses. J Autoimmun 2002 0.88
31 Altered red cell turnover in diabetic mice. J Lab Clin Med 2002 0.88
32 A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood 2011 0.88
33 ATP8A1 activity and phosphatidylserine transbilayer movement. J Receptor Ligand Channel Res 2008 0.85
34 A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica 2013 0.84
35 Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin 2006 0.84
36 Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem 2012 0.84
37 Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells. J Lipid Res 2008 0.84
38 Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal 2015 0.82
39 Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci 2005 0.81
40 Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol 2011 0.81
41 Eukaryotic protein recruitment into the Chlamydia inclusion: implications for survival and growth. PLoS One 2012 0.80
42 Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci 2005 0.80
43 Remodeling of host phosphatidylcholine by Chlamydia acyltransferase is regulated by acyl-CoA binding protein ACBD6 associated with lipid droplets. Microbiologyopen 2015 0.80
44 Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol 2006 0.79
45 Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg 2005 0.79
46 Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood 2005 0.78
47 Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Exp Biol Med (Maywood) 2011 0.78
48 Flow cytometric determination of PMCA-mediated Ca2+-extrusion in individual red blood cells. Cytometry A 2007 0.78
49 Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease. Ann N Y Acad Sci 2005 0.78
50 A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress. Blood Cells Mol Dis 2012 0.77
51 Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED. Am J Emerg Med 2010 0.76
52 Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol 2008 0.76
53 RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep 2013 0.75
54 Research in athletes with sickle cell trait: just do it. J Appl Physiol (1985) 2012 0.75